Step counting for fatty liver disease management
Part of Digestive system, Heart & circulation, Hormones & metabolism clinical trials.
This trial tests if using a pedometer to track daily steps can help people with a type of fatty liver disease (called MASLD) become more active and improve their health. It may be a good fit if you are not already very active and want to try a simple way to manage your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with MASLD (fatty liver disease not caused by alcohol) and have metabolic syndrome symptoms.
- You are at least 18 years old.
- You are willing to have a blood test to check for a gene related to fatty liver.
- You do NOT already exercise 20 minutes a day, 3 days a week, or walk more than 3,000 steps daily.
- You do NOT have other serious liver diseases, certain other illnesses, or take specific medications that affect fatty liver.
- You are not pregnant and do not have any reason you cannot have an MRI scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a liver stiffness measurement to a lifestyle program helps people with MASLD (a type of fatty liver disease) improve their liver health. It is designed for people who have fatty liver and at least one sign of metabolic syndrome, like high blood pressure or diabetes.
This study looks at a new non-invasive screening method to predict metabolic dysfunction–associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. The goal is to help identify people who may be at risk without needing invasive tests.
This study tests a new way to help people with fatty liver disease (MASLD or MASH) become more physically active. You'll use a computer to participate, and the goal is to see if this approach is acceptable and helpful for people like you.
This study tests electronic tools to help doctors identify and care for patients with steatotic liver disease (fatty liver). If you have risk factors like diabetes or elevated liver enzymes, this trial may help improve your care.
This study checks how fatty liver disease (a condition where fat builds up in the liver) affects the heart. If you have this liver condition and are between 18 and 65, you may help doctors understand the link between liver health and heart function.
This research studies fatty liver disease linked to metabolic problems like diabetes and obesity. You'll wear a fitness tracker and have liver imaging to help doctors understand the disease and find new treatments.
Hear when a new MASLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.